TherapeuticsMD, Inc. (TXMD)
1.75
-0.09
(-4.89%)
USD |
NASDAQ |
Dec 12, 16:00
1.76
+0.01
(+0.57%)
After-Hours: 20:00
TherapeuticsMD EPS Diluted (Quarterly): 0.0131 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Eli Lilly & Co. | 6.211 |
| Pfizer Inc. | 0.6197 |
| AbbVie, Inc. | 0.0993 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.05M |
| Revenue (Quarterly) | 0.784M |
| Total Expenses (Quarterly) | 0.734M |
| Enterprise Value | 19.62M |
| Gross Profit Margin (Quarterly) | 87.76% |
| Profit Margin (Quarterly) | 6.38% |
| Earnings Yield | 1.49% |
| Normalized Earnings Yield | 1.931 |